Neoadjuvant Chemotherapy With Camrelizumab in Locally Advanced Esophageal Squamous Cell
Status:
Recruiting
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
A prospective, single arm, single center, phase II clinical trial of neoadjuvant chemotherapy
with camrelizumab in locally advanced esophageal squamous cell,to evaluate the progression
free survival